EcoDrugPlus

Cyclin-Dependent Kinase 6

Ensembl ID : ENSNFUG00015024758
Gene Symbol: CDK6
1 Cross references
200 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1-Like

Ensembl ID : ENSNFUG00015002490
Gene Symbol: LOC107375567
3 Cross references
172 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSNFUG00015019437
Gene Symbol: CDA
3 Cross references
200 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSNFUG00015001215
Gene Symbol: CYP17A1
1 Cross references
210 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSNFUG00015009294
Gene Symbol: CYP19A1A
1 Cross references
249 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily A, Polypeptide 65

Ensembl ID : ENSNFUG00015007369
Gene Symbol: CYP3A65
1 Cross references
549 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily C, Polypeptide 4

Ensembl ID : ENSNFUG00015005316
Gene Symbol: CYP3C4
1 Cross references
536 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSNFUG00015012114
Gene Symbol: LOC107383789
3 Cross references
197 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSNFUG00015023936
Gene Symbol: LOC107376047
3 Cross references
179 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSNFUG00015016137
Gene Symbol: DGAT1
1 Cross references
189 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSNFUG00015021711
Gene Symbol: LOC107394608
3 Cross references
190 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSNFUG00015017457
Gene Symbol: DHODH
3 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).